A randomised prospective open multi-attack study of patient preference and efficacy between zolmitriptan nasal spray 5 mg and sumatriptan RDT 100 mg in the acute treatment of migraine.
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2011
At a glance
- Drugs Zolmitriptan (Primary) ; Sumatriptan
- Indications Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- 12 Jul 2011 New trial record